Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions

Myelodysplastic syndromes (MDS) comprise a heterogeneous group of myeloid neoplasms characterized by peripheral cytopenia, dysplasia, and a variable clinical course with about 30% risk to transform to secondary acute myeloid leukemia (AML). In the past 15 years, diagnostic evaluations, prognosticati...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Valent, Peter, Orazi, Attilio, Steensma, David P., Ebert, Benjamin L., Haase, Detlef, Malcovati, Luca, van de Loosdrecht, Arjan A., Haferlach, Torsten, Westers, Theresia M., Wells, Denise A., Giagounidis, Aristoteles, Loken, Michael, Orfao, Alberto, Lübbert, Michael, Ganser, Arnold, Hofmann, Wolf-Karsten, Ogata, Kiyoyuki, Schanz, Julie, Béné, Marie C., Hoermann, Gregor, Sperr, Wolfgang R., Sotlar, Karl, Bettelheim, Peter, Stauder, Reinhard, Pfeilstöcker, Michael, Horny, Hans-Peter, Germing, Ulrich, Greenberg, Peter, Bennett, John M.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Priority Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5650276/
https://ncbi.nlm.nih.gov/pubmed/29088721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados